Skip to main content

Organigram Holdings Inc (OGI-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 3.63
Day High 4.38
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

OrganiGram Holdings Inc is a Canada licensed producer of cannabis products. The company focuses on producing indoor-growth cannabis for patients and adult recreational consumers, as well as developing overseas business partnerships.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Regulators Strive to Limit Illicit Cannabis Trade as the Industry Continues its Expansion
- PR Newswire - Thu Oct 10, 8:00AM CDT
PR Newswire - CMTX
Thu Oct 10, 8:00AM CDT
Most regions around the world allow young adults at the age of 18 to enjoy or purchase their own alcohol and tobacco. However, the U.S. has strictly enforced that adults must be 21 years old or older in order to purchase alcohol. Meanwhile, some parts of the U.S. have also implemented a mandated age of 21 years or older to purchase tobacco. The U.S. government strongly believed that if the minimum age requirement was raised to 21 it would reduce the number of young adults drinking and smoking. However, Mike Males, a Senior Researcher for San Francisco's Center on Juvenile and Criminal Justice, highlighted that changing the age limit has little to no effect in the reduction of underage users. Additionally, teenagers are more likely to obtain their supply from an illegal source and consequently, teenagers are more likely to drink or smoke in excess. Similarly, as the legal cannabis market begins to take off, lawmakers are approaching the industry with caution. In U.S. states where cannabis is legal for adult-use, only adults 21 years old and over are allowed to purchase any cannabis-based products. On the other hand, Canada allows consumers 18 years old and older (19 years old in some provinces) to purchase cannabis-based products. The age difference between the two countries allows Canada to minimize the illicit trade market. Similarly, the United States setting the legal age at 18 years old would add a whole new demographic of young adults to the market, expanding the market penetration even further. And according to data compiled by Imarc Group, the North American legal cannabis market is expected to reach USD 35 Billion by 2023 from USD 8 Billion in 2017. Additionally, the market is expected to register a healthy CAGR of 28% throughout the forecast period. Global Payout, Inc. (OTC: GOHE), The Supreme Cannabis Company, Inc. (OTC: SPRWF) (TSX: FIRE), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH), 22nd Century Group, Inc. (NYSE: XXII), Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI)
Consumers Turn to CBD as a Myriad of Cannabis Products Hit the Shelves
- PR Newswire - Fri Oct 4, 8:00AM CDT
PR Newswire - CMTX
Fri Oct 4, 8:00AM CDT
Earlier last year, Canada legalized cannabis for recreational use. Now, combined with the continued efforts in the U.S., a plethora of recreational cannabis dispensaries have begun to emerge. Recreational dispensaries sell a variety of cannabis-based products including flowers, oils, tinctures, topicals and many more. And along with the dispensaries, came the widespread understanding that tolerance plays a big role in cannabis use. For example, a 1:1 CBD to THC ratio is a balanced potency and recommended for users who can handle the psychoactive properties of THC. On the other hand, less enthusiastic users could be more inclined to purchase an 18:1 CBD to THC ratio product. An 18:1 ratio is high in CBD and is geared towards more casual users who don't intend to get 'high', according to Care By Design. CBD is the non-psychoactive component of the cannabis plant, while THC is known as its psychoactive derivative. Generally, recreational dispensaries sell more highly concentrated THC products, while medical facilities are more likely to offer more powerful CBD products. Notably, CBD and THC levels can be altered with the use of special farming techniques, altering how many trichomes are on the plant. Trichomes can be found on various plants, however, on the cannabis plant, trichomes can determine the strain's potency and effectiveness. And according to data compiled by Verified Market Research, the global marijuana market was valued at USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025. Smart Decision, Inc. (OTC: SDEC), OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), KushCo Holdings, Inc. (OTC: KSHB)
Cannabis Consumers Reap the Benefits of Cultivator Innovation
- PR Newswire - Thu Sep 26, 8:00AM CDT
PR Newswire - CMTX
Thu Sep 26, 8:00AM CDT
Throughout the evolution of the cannabis industry, savvy cultivators have designed innovative and refreshingly new strains for consumers. Cannabis has been prevalent for centuries and the earliest species of cannabis strains were known to grow around the mountainous Hindu Kush region of Pakistan. The region was deemed perfect for growing cannabis because of its environmental factors, but after years of adaptations, growers realized that cannabis grows much better in tropical climates. Predominantly, many cannabis cultivators grow their plants outdoors, however, with prohibition sweeping throughout the world, they were forced to retreat into indoor grow houses. And, beginning in the 1970s and 1980s, many cultivators began to grow cannabis underground or in indoor facilities that were powered by electrical lightings and hydroponic systems. Then, in the 1990s, cannabis legalization efforts began in the U.S. after California legalized cannabis for medical applications. Shortly after, more U.S. states and countries abroad began to adopt their own cannabis legislation. However, even after decades of legalization efforts, cannabis is still primarily grown within indoor facilities. Many cultivators tend to prefer indoor grow houses because it gives them full control over the environmental factors, thus allowing them to grow cannabis anywhere in the world regardless of climate. For instance, if a cultivator is growing a plethora of tall and bulky plants, they could easily dial up the irrigation system and amp up airflow throughout the facility. Overall, the total control of an indoor facility allows cultivators to produce a variety of different strains. And as cultivators bring forth potent and organic products, enthusiastic consumers are eager to try them. As a result, spending on legal cannabis in Canada is projected to grow at a CAGR of 44.4% from USD 569 Million in 2018 to nearly USD 5.2 Billion by 2024, according to data compiled by Arcview Market Research and BDS Analytics. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), KushCo Holdings, Inc. (OTC: KSHB), Acreage Holdings Inc. (OTC: ACRGF) (CSE: ACRG)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 3.60 +15.83% increase
on 10/10/19
Period Open:6.22
Price movement based on the high, low and last over the given period.
6.20 -32.74% decrease
on 09/12/19
-2.05 (-32.96%) decrease
since 09/11/19
3-Month 3.60 +15.83% increase
on 10/10/19
Period Open:8.25
Price movement based on the high, low and last over the given period.
9.06 -53.97% decrease
on 07/17/19
-4.08 (-49.45%) decrease
since 07/11/19
52-Week 3.60 +15.83% increase
on 10/10/19
Period Open:7.05
Price movement based on the high, low and last over the given period.
11.30 -63.10% decrease
on 05/21/19
-2.88 (-40.85%) decrease
since 10/11/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).